Condition: Overactive Bladder Syndrome · Sponsor: Walter Reed National Military Medical Center
A single site, double-blinded, randomized controlled trial for postmenopausal women with urinary frequency, urgency, nocturia with or without urgency urinary incontinence symptoms. Patient's will be randomized between 0.01% vaginal estradiol cream with placebo oral pill or daily 50 milligrams oral Mirabegron with a placebo vaginal cream for 12 weeks.
This description comes directly from the study's public registry record.
Christopher W Heuer, DO · 2626231053 · christopher.w.heuer@gmail.com
Katherine L Dengler, MD · 3522626861 · katidengler12@gmail.com
Always discuss trial participation with your own doctor first.
| Walter Reed National Military Medical Center | Bethesda, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05221021